The global human respiratory syncytial virus drugs market is expected to grow at a CAGR of more than 4% during the forecast period, according to Technavio’s latest report. #Hashtags.

Respiratory syncytial virus (RSV), originally recovered from a colony of chimpanzees with coryza and designated chimpanzee coryza agent,1,2 and human parainfluenza virus types 1, 2, 3, and 4 have b ...

Respiratory syncytial virus (RSV) infection causes substantial morbidity and mortality among infants, older adults, and immunocompromised adults. EDP-938, a nonfusion replication inhibitor of RSV, ...

Researchers have developed a new antiviral strategy to fight human respiratory syncytial virus (RSV), a leading cause of lower respiratory tract infections in children. The approach hinges on the ...

Health officials reported that cases of human metapneumovirus (HMPV) spiked this spring as COVID-19 and Respiratory Syncytial Virus cases fell. National data from the Centers for Disease Control ...

Respiratory syncytial virus (RSV) is a highly contagious and seasonal respiratory virus that mainly causes common cold symptoms in healthy adults but can cause more serious lung infections in ...

We describe the epidemiologic and clinical characteristics of 111 children attending clinics and hospitals in Aracaju, northeast Brazil, with acute respiratory infections attributable to human ...

Human metapneumovirus is a common respiratory virus discovered in 2001 that causes an upper, ... Loveday said HMPV is in the pneumoviridae family which includes respiratory syncytial virus.

Study shows key role for human T cells in the control of Respiratory Syncytial Virus (RSV) infection. ScienceDaily . Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2023 / 05 ...